Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hypoxia-An overlooked trigger for thrombosis in COVID-19 and other critically ill patients.

Literature DB >> 32726507

Hypoxia-An overlooked trigger for thrombosis in COVID-19 and other critically ill patients.

Jecko Thachil¹.

Abstract

Entities: Disease Species

Year: 2020 PMID： 32726507 DOI： 10.1111/jth.15029

Source DB: PubMed Journal: J Thromb Haemost ISSN： 1538-7836 Impact factor: 5.824

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

Review 1. Mechanisms of COVID-19 thrombosis in an inflammatory environment and new anticoagulant targets.

Authors: Huan Liu; Tianshui Hu; Cong Zhang; Xiaojing Chen; Shuoqi Zhang; Mengdi Li; Haijiao Jing; Chunxu Wang; Tenglong Hu; Jialan Shi
Journal: Am J Transl Res Date: 2021-05-15 Impact factor: 4.060

Review 2. Post-acute COVID-19 syndrome.

Authors: Ani Nalbandian; Kartik Sehgal; Aakriti Gupta; Mahesh V Madhavan; Claire McGroder; Jacob S Stevens; Joshua R Cook; Anna S Nordvig; Daniel Shalev; Tejasav S Sehrawat; Neha Ahluwalia; Behnood Bikdeli; Donald Dietz; Caroline Der-Nigoghossian; Nadia Liyanage-Don; Gregg F Rosner; Elana J Bernstein; Sumit Mohan; Akinpelumi A Beckley; David S Seres; Toni K Choueiri; Nir Uriel; John C Ausiello; Domenico Accili; Daniel E Freedberg; Matthew Baldwin; Allan Schwartz; Daniel Brodie; Christine Kim Garcia; Mitchell S V Elkind; Jean M Connors; John P Bilezikian; Donald W Landry; Elaine Y Wan
Journal: Nat Med Date: 2021-03-22 Impact factor: 53.440

3. A Review of Pathophysiology, Clinical Features, and Management Options of COVID-19 Associated Coagulopathy.

Authors: Julie Goswami; Taleen A MacArthur; Meera Sridharan; Rajiv K Pruthi; Robert D McBane; Thomas E Witzig; Myung S Park
Journal: Shock Date: 2021-06-01 Impact factor: 3.533

4. Differentiating biochemical from clinical heparin resistance in COVID-19.

Authors: Ton Lisman; Jecko Thachil
Journal: J Thromb Thrombolysis Date: 2020-11 Impact factor: 2.300

Review 5. The lung-gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes.

Authors: Valentin Sencio; Marina Gomes Machado; François Trottein
Journal: Mucosal Immunol Date: 2021-01-26 Impact factor: 7.313

Review 10. COVID-19 Infection: Viral Macro- and Micro-Vascular Coagulopathy and Thromboembolism/Prophylactic and Therapeutic Management.

Authors: Antonis S Manolis; Theodora A Manolis; Antonis A Manolis; Despoina Papatheou; Helen Melita
Journal: J Cardiovasc Pharmacol Ther Date: 2020-09-14 Impact factor: 2.457

Hypoxia-An overlooked trigger for thrombosis in COVID-19 and other critically ill patients.

Review 1. Mechanisms of COVID-19 thrombosis in an inflammatory environment and new anticoagulant targets.

Review 2. Post-acute COVID-19 syndrome.

3. A Review of Pathophysiology, Clinical Features, and Management Options of COVID-19 Associated Coagulopathy.

4. Differentiating biochemical from clinical heparin resistance in COVID-19.

Review 5. The lung-gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes.

6. HIF-1α Cardioprotection in COVID-19 Patients.

Review 7. COVID-19 and thrombotic complications-the role of anticoagulants, antiplatelets and thrombolytics.

8. Acute complete splenic infarction secondary to COVID-19 infection.

Review 9. COVID-19 and central nervous system interplay: A big picture beyond clinical manifestation.

Review 10. COVID-19 Infection: Viral Macro- and Micro-Vascular Coagulopathy and Thromboembolism/Prophylactic and Therapeutic Management.